- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2008
- Public Summary Document (PSD) March 2008 PBAC Meeting - PDF
Imatinib mesylate – March 2008
Imatinib mesylate, tablets, 100 mg and 400 mg (base), Glivec, March 2008
Last updated
4 July 2008